Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

NCT00003731 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: temozolomide

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC